CN105709165A - Chinese patent medicine electuary for treating erosive-type psoriasis - Google Patents
Chinese patent medicine electuary for treating erosive-type psoriasis Download PDFInfo
- Publication number
- CN105709165A CN105709165A CN201410704303.1A CN201410704303A CN105709165A CN 105709165 A CN105709165 A CN 105709165A CN 201410704303 A CN201410704303 A CN 201410704303A CN 105709165 A CN105709165 A CN 105709165A
- Authority
- CN
- China
- Prior art keywords
- radix
- liquid
- time
- weight
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine electuary for treating erosive-type psoriasis, which belongs to the field of pharmacy. The traditional Chinese medicine electuary comprises the following raw materials: 10% of root of large-flowered skullcap, 9% of radix paeoniae rubrathe, 7% of phellodendron, 5% of raw rehmannia root, 7% of sophora flower, 6% of tree peony bark, 8% of lithospermum, 7% of catnip, 8% of radix saposhnikoviae, 7% of radix bupleuri, 6% of curcuma tuber, 7% of rhizoma atractylodis, 6% of sophora flavescens, 7% of cortex dictamni, and a proper amount of water. A clear paste prepared by a decoction of the above traditional Chinese medicines accounts for 70-75% of final quantity, cane sugar and dextrin with a proportion of 1: 1.5 account for 25-30% of that of the raw materials, the product is prepared by steps of decocting, blending, granulating and drying, and the product is used for treating erosive-type psoriasis. After the electuary is administrated, high-concentration effective component of the traditional Chinese medicine electuary can be rapidly transmitted to whole body, and the traditional Chinese medicine electuary has good efficacy for regulating qi and blood, balancing Yin and Yang, dredging meridians, warming meridians to dissipate cold, dispelling wind and dehumidifying, clearing heat and detoxifying, diminishing swelling, dissolving stasis, relaxing vein and relieving itching, nourishing and promoting tissue regeneration, and detoxifying to remove spots.
Description
Technical field:
Product of the present invention belongs to pharmaceutical field, particularly relates to one and treats the psoriasic Chinese patent medicine granule of erosive type.
Background technology:
Psoriasis is the dermatosis of a kind of common chronic stubbornness, brings heavy thought pressure to patient after ill, and it animally brings misery not only to patient, more makes normal person produce patient detest and hide psychology.It it is syringe needle extremely lentil-sized inflammatory flat pimple during psoriasis onset, it is gradually increased and infiltrates speckle for coin or bigger pale red, boundary is clear, overlying multilamellar silvery white squama, in this sick evolution, skin lesion can occur in any site symmetry of health, be apt to occur in elbow, knee joint stretches side and head, the easy acute attack of psoriasis, and morbidity is often relevant with season, have exacerbate summer, autumn and winter spontaneous recovery person;Also having Winter-Spring to recur, summer has set in alleviator, its pathogenic factor is very complicated, and it is often invalid to carry out treating with antifungal drug.Chinese traditional treatment psoriasis main method is: oral Chinese medicine, oral Chinese patent medicine granule, use treatment liquid washout.Oral Chinese medicine is to treat psoriasic conventional effective method, has effect and is better than the series of advantages such as Western medicine, side effect is little, medication is cheap, it is possible to using with outer washing medicine combination, shortcoming is to take inconvenience.In order to overcome Chinese medicine to take the defect of inconvenience, the present invention provides one to treat the psoriasic Chinese patent medicine granule of erosive type, with Radix Scutellariae, Radix Paeoniae Rubra, Cortex Phellodendri, Radix Rehmanniae, Flos Sophorae, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Herba Schizonepetae, Radix Saposhnikoviae, Radix Bupleuri, Radix Curcumae, Rhizoma Atractylodis, Radix Sophorae Flavescentis, Cortex Dictamni is that raw material passes through to boil technique and obtains herb liquid, then electuary is made as major ingredient, after this electuary is taken, the effective ingredient of high concentration reaches rapidly whole body, there is QI and blood regulating, Yin Yang balancing, dredging the meridian, dispelling cold by warming the meridian, expelling wind and removing dampness, heat-clearing and toxic substances removing, detumescence, vein-relaxing itching-relieving, flourish foster granulation promoting, toxin expelling moves back the good effects of speckle.
Summary of the invention
The problem that present invention mainly solves is to provide one and treats the psoriasic Chinese patent medicine granule of erosive type, producing the raw material that this product uses is by weight ratio: medical material weight ratio is that Radix Scutellariae 10%, Radix Paeoniae Rubra 9%, Cortex Phellodendri 7%, Radix Rehmanniae 5%, Flos Sophorae 7%, Cortex Moutan 6%, Radix Arnebiae (Radix Lithospermi) 8%, Herba Schizonepetae 7%, Radix Saposhnikoviae 8%, Radix Bupleuri 7%, Radix Curcumae 6%, Rhizoma Atractylodis 7%, Radix Sophorae Flavescentis 6%, Cortex Dictamni 7%, water are appropriate, boiling, with above-mentioned Chinese crude drug, the clear paste that medicinal liquid makes and account for the 70%-75% of final weight, sucrose and dextrin account for the 25%-30% of final weight by the proportions product of 1:1.5.
The present invention can be achieved through the following technical solutions:
One treats the psoriasic Chinese patent medicine granule of erosive type, and its compound method is made up of following steps:
(1) Radix Scutellariae of formula ratio, Radix Paeoniae Rubra, Cortex Phellodendri, Radix Rehmanniae, Flos Sophorae, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Herba Schizonepetae, Radix Saposhnikoviae, Radix Bupleuri, Radix Curcumae, Rhizoma Atractylodis, Radix Sophorae Flavescentis, Cortex Dictamni are sent into and boiled container, first time adds the water of medical material weight 5 times and boils, and the time is pour out a liquid after 1.8-2.0 hour;Second time is added the water of medical material weight 4 times and is boiled, and the time is pour out two liquid after 1.5-1.7 hour, will send into thickener after head liquid, two liquid elimination impurity;
(2) the head liquid in thickener, two liquid concentrations being become the clear paste that relative density is 1.4, weight accounts for the 70%-75% of total amount;
(3) after sucrose and dextrin being mixed in the ratio of 1:1.5, weight accounts for the 25%-30% of total amount, and after clear paste mixing, stirs with Mixing Machine, pulverize after drying, get product.
The further technical scheme of the present invention is:
It is 1.9 hours that head liquid described in step (1) boils the time;It is 1.6 hours that two liquid boil the time.
The invention has the beneficial effects as follows: provide one and treat the psoriasic Chinese patent medicine granule of erosive type, this product processes is simple, the drug administration produced is convenient, side effect is little, it is adapted to treatment erosive type psoriasis, after this electuary is taken, the effective ingredient of high concentration reaches rapidly whole body, has QI and blood regulating, Yin Yang balancing, dredging the meridian, dispelling cold by warming the meridian, expelling wind and removing dampness, heat-clearing and toxic substances removing, detumescence, vein-relaxing itching-relieving, flourish supports granulation promoting, toxin expelling moves back the good effects of speckle.
Detailed description of the invention:
Embodiment 1:
By medical material weight ratio be Radix Scutellariae 10%, Radix Paeoniae Rubra 9%, Cortex Phellodendri 7%, Radix Rehmanniae 5%, Flos Sophorae 7%, Cortex Moutan 6%, Radix Arnebiae (Radix Lithospermi) 8%, Herba Schizonepetae 7%, Radix Saposhnikoviae 8%, Radix Bupleuri 7%, Radix Curcumae 6%, Rhizoma Atractylodis 7%, Radix Sophorae Flavescentis 6%, Cortex Dictamni 7% Chinese crude drug send into boil container, first time adds the water of medical material weight 5 times and boils, and the time is pour out a liquid after 1.8 hours;Second time is added the water of medical material weight 4 times and is boiled, and the time is pour out two liquid after 1.7 hours, will send into thickener after head liquid, two liquid elimination impurity;Head liquid in thickener, two liquid concentrations are become the clear paste that relative density is 1.4, and weight accounts for the 70% of total amount;After sucrose and dextrin being mixed in the ratio of 1:1.5, weight accounts for the 30% of total amount, and after clear paste mixing, stirs with Mixing Machine, pulverize after drying, get product.
Embodiment 2:
By medical material weight ratio be Radix Scutellariae 10%, Radix Paeoniae Rubra 9%, Cortex Phellodendri 7%, Radix Rehmanniae 5%, Flos Sophorae 7%, Cortex Moutan 6%, Radix Arnebiae (Radix Lithospermi) 8%, Herba Schizonepetae 7%, Radix Saposhnikoviae 8%, Radix Bupleuri 7%, Radix Curcumae 6%, Rhizoma Atractylodis 7%, Radix Sophorae Flavescentis 6%, Cortex Dictamni 7% Chinese crude drug send into boil container, first time adds the water of medical material weight 5 times and boils, and the time is pour out a liquid after 1.9 hours;Second time is added the water of medical material weight 4 times and is boiled, and the time is pour out two liquid after 1.6 hours, will send into thickener after head liquid, two liquid elimination impurity;Head liquid in thickener, two liquid concentrations are become the clear paste that relative density is 1.4, and weight accounts for the 72.5% of total amount;After sucrose and dextrin being mixed in the ratio of 1:1.5, weight accounts for the 27.5% of total amount, and after clear paste mixing, stirs with Mixing Machine, pulverize after drying, get product.
Embodiment 3:
By medical material weight ratio be Radix Scutellariae 10%, Radix Paeoniae Rubra 9%, Cortex Phellodendri 7%, Radix Rehmanniae 5%, Flos Sophorae 7%, Cortex Moutan 6%, Radix Arnebiae (Radix Lithospermi) 8%, Herba Schizonepetae 7%, Radix Saposhnikoviae 8%, Radix Bupleuri 7%, Radix Curcumae 6%, Rhizoma Atractylodis 7%, Radix Sophorae Flavescentis 6%, Cortex Dictamni 7% Chinese crude drug send into boil container, first time adds the water of medical material weight 5 times and boils, and the time is pour out a liquid after 2.0 hours;Second time is added the water of medical material weight 4 times and is boiled, and the time is pour out two liquid after 1.5 hours, will send into thickener after head liquid, two liquid elimination impurity;Head liquid in thickener, two liquid concentrations are become the clear paste that relative density is 1.4, and weight accounts for the 75% of total amount;After sucrose and dextrin being mixed in the ratio of 1:1.5, weight accounts for the 25% of total amount, and after clear paste mixing, stirs with Mixing Machine, pulverize after drying, get product.
Claims (2)
1. the treatment psoriasic Chinese patent medicine granule of erosive type, the raw material of its use includes by weight ratio: the weight ratio of Chinese crude drug is that Radix Scutellariae 10%, Radix Paeoniae Rubra 9%, Cortex Phellodendri 7%, Radix Rehmanniae 5%, Flos Sophorae 7%, Cortex Moutan 6%, Radix Arnebiae (Radix Lithospermi) 8%, Herba Schizonepetae 7%, Radix Saposhnikoviae 8%, Radix Bupleuri 7%, Radix Curcumae 6%, Rhizoma Atractylodis 7%, Radix Sophorae Flavescentis 6%, Cortex Dictamni 7%, water are appropriate, boiling, with above-mentioned Chinese crude drug, the clear paste that medicinal liquid makes and account for the 70%-75% of final weight, sucrose and dextrin account for the 25%-30% of final weight by the proportions product of 1:1.5;It is characterized in that:
(1) Radix Scutellariae of formula ratio, Radix Paeoniae Rubra, Cortex Phellodendri, Radix Rehmanniae, Flos Sophorae, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Herba Schizonepetae, Radix Saposhnikoviae, Radix Bupleuri, Radix Curcumae, Rhizoma Atractylodis, Radix Sophorae Flavescentis, Cortex Dictamni are sent into and boiled container, first time adds the water of medical material weight 5 times and boils, and the time is pour out a liquid after 1.8-2.0 hour;Second time is added the water of medical material weight 4 times and is boiled, and the time is pour out two liquid after 1.5-1.7 hour, will send into thickener after head liquid, two liquid elimination impurity;
(2) the head liquid in thickener, two liquid concentrations being become the clear paste that relative density is 1.4, weight accounts for the 70%-75% of total amount;
(3) after sucrose and dextrin being mixed in the ratio of 1:1.5, weight accounts for the 25%-30% of total amount, and after clear paste mixing, stirs with Mixing Machine, pulverize after drying, get product.
2. the psoriasic Chinese patent medicine granule for the treatment of erosive type according to claim 1, is characterized in that: it is 1.9 hours that the head liquid described in step (1) boils the time;It is 1.6 hours that two liquid boil the time.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410704303.1A CN105709165A (en) | 2014-12-01 | 2014-12-01 | Chinese patent medicine electuary for treating erosive-type psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410704303.1A CN105709165A (en) | 2014-12-01 | 2014-12-01 | Chinese patent medicine electuary for treating erosive-type psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105709165A true CN105709165A (en) | 2016-06-29 |
Family
ID=56145713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410704303.1A Pending CN105709165A (en) | 2014-12-01 | 2014-12-01 | Chinese patent medicine electuary for treating erosive-type psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105709165A (en) |
-
2014
- 2014-12-01 CN CN201410704303.1A patent/CN105709165A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
CN106822316A (en) | A kind of invigorate blood circulation smokeless moxibustion bar and preparation method thereof | |
CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN104491052A (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
CN103705849A (en) | Traditional Chinese medicine for treating bronchial asthma | |
CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
CN104000893A (en) | Traditional Chinese medicine oral liquid for treating rhinitis | |
CN103948768A (en) | Traditional Chinese medicine preparation for treating rheumatism and rheumatoid arthritis | |
CN103341013B (en) | A kind of Chinese medicine for the treatment of lumbago and skelalgia | |
CN104587414A (en) | Traditional Chinese medicinal composition for treating headache | |
CN104689144A (en) | Drug for treating rheumatoid arthritis | |
CN103705850A (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN105616685A (en) | Traditional Chinese medicinal oral liquid for treating erythra type psoriasis | |
CN105616643A (en) | Traditional Chinese medicinal treatment liquid for treating erosive psoriasis | |
CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
CN105709164A (en) | Chinese patent medicine oral liquid for treating erosive-type psoriasis | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN105709165A (en) | Chinese patent medicine electuary for treating erosive-type psoriasis | |
CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
CN103599491A (en) | Medicine for treating ulcer and sore yang pattern and preparation method thereof | |
CN105708962A (en) | Chinese patent medicine electuary for treating erosive-type psoriasis | |
CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness | |
CN102743661B (en) | A kind of antipsoriatics thing and preparation method thereof | |
CN101983712A (en) | Novel medicament for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160629 |
|
WD01 | Invention patent application deemed withdrawn after publication |